Skip to main content

  • Percutaneous Coronary Intervention With an Initial Bolus of Low-Dose Heparin in Biomarker-Negative Patients

    • Posted: 02/28/2021
    • Author:

      Michael S. Lee, Seung-Woon Rha, Richard Shlofmitz

    • 2021CRM

    Abstract

    Objectives

    The safety and efficacy of an initial intravenous bolus of low-dose heparin (40 IU/kg) was evaluated in biomarker negative patients undergoing percutaneous coronary intervention (PCI).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details